Cas:403845-70-5 N-(1-adamantyl)-4-bromobenzamide manufacturer & supplier

Chemical Name:N-(1-adamantyl)-4-bromobenzamide

CAS.NO:403845-70-5

Synonyms:N-adamantyl-4-bromobenzamide

Molecular Formula:C₁₇H₂₀BrNO

Molecular Weight:334.25100

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:29.10000

Exact Mass:333.07300

LogP:4.53860

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-adamantyl-4-bromobenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-adamantyl-4-bromobenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-adamantyl-4-bromobenzamide Use and application,N-adamantyl-4-bromobenzamide technical grade,usp/ep/jp grade.

Related News: As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 6-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-1-ethyl-4-methyl-3,4-dihydroquinolin-2(1H)-one manufacturers Prime Minister Naftali Bennett, launching the campaign, said President Isaac Herzog would be the first to receive the booster, on Friday. 19-Hydroxy-3β,17α-diacetoxy-20-oxo-pregnen-(5) suppliers Novartis and GSK carried out a swap of its vaccine and cancer drugs back in 2015. GSK paid $5.25 billion to Novartis for its vaccine business, and Novartis sent $16 billion for GSK’s oncology programs. Tafinlar and Mekinist had already been granted FDA approval at the time of that deal, and as a part of that deal, Novartis agreed to divest its own BRAF and MEK inhibitors to avoid creating a monopoly. 1,1,1-trifluoro-3-hydroxy-5,9-dimethyldecan-2-one vendor & factory.